Florence A. Scholl

1.4k total citations
20 papers, 1.2k citations indexed

About

Florence A. Scholl is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Florence A. Scholl has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Florence A. Scholl's work include Melanoma and MAPK Pathways (5 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Florence A. Scholl is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Florence A. Scholl collaborates with scholars based in Switzerland, United States and Canada. Florence A. Scholl's co-authors include Beat W. Schäfer, Paul A. Khavari, Phillip A. Dumesic, Deborah I. Barragan, Jean Charron, Kazutoshi Harada, Bashar Saad, Peter Maier, Roland Wicki and Claus W. Heizmann and has published in prestigious journals such as The Journal of Cell Biology, Cancer Cell and Cancer Research.

In The Last Decade

Florence A. Scholl

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florence A. Scholl Switzerland 16 826 249 178 168 148 20 1.2k
Shideh Kazerounian United States 14 639 0.8× 186 0.7× 172 1.0× 122 0.7× 195 1.3× 20 1.1k
Hoanh Tran United States 16 1.1k 1.3× 282 1.1× 162 0.9× 120 0.7× 225 1.5× 21 1.5k
Jolanta Niewiarowska Poland 18 493 0.6× 208 0.8× 145 0.8× 123 0.7× 228 1.5× 39 947
Carl V. Hamby United States 16 545 0.7× 311 1.2× 128 0.7× 228 1.4× 119 0.8× 39 1.0k
Kai Doberstein Germany 19 524 0.6× 299 1.2× 65 0.4× 182 1.1× 249 1.7× 27 1.1k
Francine Grondin Canada 12 433 0.5× 144 0.6× 124 0.7× 97 0.6× 184 1.2× 16 851
Habib Boukerche France 20 809 1.0× 504 2.0× 309 1.7× 251 1.5× 196 1.3× 33 1.6k
Miguel Aracil Spain 20 679 0.8× 349 1.4× 90 0.5× 199 1.2× 268 1.8× 41 1.3k
Charlotte E. Edling United Kingdom 14 606 0.7× 273 1.1× 81 0.5× 136 0.8× 124 0.8× 32 1.0k

Countries citing papers authored by Florence A. Scholl

Since Specialization
Citations

This map shows the geographic impact of Florence A. Scholl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence A. Scholl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence A. Scholl more than expected).

Fields of papers citing papers by Florence A. Scholl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florence A. Scholl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence A. Scholl. The network helps show where Florence A. Scholl may publish in the future.

Co-authorship network of co-authors of Florence A. Scholl

This figure shows the co-authorship network connecting the top 25 collaborators of Florence A. Scholl. A scholar is included among the top collaborators of Florence A. Scholl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florence A. Scholl. Florence A. Scholl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dumesic, Phillip A., Florence A. Scholl, Deborah I. Barragan, & Paul A. Khavari. (2009). Erk1/2 MAP kinases are required for epidermal G2/M progression. The Journal of Cell Biology. 185(3). 409–422. 80 indexed citations
2.
Reuter, Jason, Susana Ortiz‐Urda, Markus Kretz, et al.. (2009). Modeling Inducible Human Tissue Neoplasia Identifies an Extracellular Matrix Interaction Network Involved in Cancer Progression. Cancer Cell. 15(6). 477–488. 68 indexed citations
3.
Scholl, Florence A., Phillip A. Dumesic, Deborah I. Barragan, Jean Charron, & Paul A. Khavari. (2009). Mek1/2 gene dosage determines tissue response to oncogenic Ras signaling in the skin. Oncogene. 28(12). 1485–1495. 19 indexed citations
4.
Scholl, Florence A., Phillip A. Dumesic, Deborah I. Barragan, et al.. (2009). Selective Role for Mek1 but not Mek2 in the Induction of Epidermal Neoplasia. Cancer Research. 69(9). 3772–3778. 45 indexed citations
5.
Scholl, Florence A., Phillip A. Dumesic, Deborah I. Barragan, et al.. (2007). Mek1/2 MAPK Kinases Are Essential for Mammalian Development, Homeostasis, and Raf-Induced Hyperplasia. Developmental Cell. 12(4). 615–629. 121 indexed citations
6.
Scholl, Florence A., Phillip A. Dumesic, & Paul A. Khavari. (2005). Effects of active MEK1 expression in vivo. Cancer Letters. 230(1). 1–5. 40 indexed citations
7.
Scholl, Florence A., Phillip A. Dumesic, & Paul A. Khavari. (2004). Mek1 Alters Epidermal Growth and Differentiation. Cancer Research. 64(17). 6035–6040. 67 indexed citations
8.
Siprashvili, Zurab, Florence A. Scholl, Steven F. Oliver, et al.. (2003). Gene Transfer via Reversible Plasmid Condensation with Cysteine-Flanked, Internally Spaced Arginine-Rich Peptides. Human Gene Therapy. 14(13). 1225–1233. 60 indexed citations
9.
Scholl, Florence A., et al.. (2001). PAX3 is expressed in human melanomas and contributes to tumor cell survival.. PubMed. 61(3). 823–6. 97 indexed citations
10.
Scholl, Florence A., Patricia McLoughlin, Elisabeth Ehler, Carla De Giovanni, & Beat W. Schäfer. (2000). Dral Is a P53-Responsive Gene Whose Four and a Half Lim Domain Protein Product Induces Apoptosis. The Journal of Cell Biology. 151(3). 495–506. 95 indexed citations
11.
Scholl, Florence A., D R Betts, Felix Niggli, & Beat W. Schäfer. (2000). Molecular features of a human rhabdomyosarcoma cell line with spontaneous metastatic progression. British Journal of Cancer. 82(6). 1239–1245. 23 indexed citations
12.
Bissig, Heidi, Irène Hösli, David R. Betts, et al.. (2000). Inv(11)(p13p15) and Myf-3(MyoD1) in a Malignant Extrarenal Rhabdoid Tumor of a Premature Newborn. Pediatric Research. 48(4). 463–467. 14 indexed citations
13.
Scholl, Florence A., et al.. (1997). Subtractive Cloning and Characterization of DRAL, a Novel LIM-Domain Protein Down-Regulated in Rhabdomyosarcoma. DNA and Cell Biology. 16(4). 433–442. 109 indexed citations
14.
Wicki, Roland, et al.. (1997). Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation. Cell Calcium. 22(4). 243–254. 111 indexed citations
15.
Scholl, Florence A., et al.. (1996). Isolation of genes differentially expressed in human primary myoblasts and embryonal rhabdomyosarcoma. International Journal of Cancer. 66(4). 571–577. 67 indexed citations
16.
Scholl, Florence A., et al.. (1996). Isolation of genes differentially expressed in human primary myoblasts and embryonal rhabdomyosarcoma. International Journal of Cancer. 66(4). 571–577. 5 indexed citations
17.
Saad, Bashar, Karl Frei, Florence A. Scholl, A. Fontana, & Peter Maier. (1995). Hepatocyte‐Derived Interleukin‐6 and Tumor‐Necrosis Factor α Mediate the Lipopolysaccharide‐Induced Acute‐Phase Response and Nitric Oxide Release by Cultured Rat Hepatocytes. European Journal of Biochemistry. 229(2). 349–355. 86 indexed citations
18.
Saad, Bashar, Karl Frei, Florence A. Scholl, A. Fontana, & Peter Maier. (1995). Hepatocyte-Derived Interleukin-6 and Tumor-Necrosis Factor alpha Mediate the Lipopolysaccharide-Induced Acute-Phase Response and Nitric Oxide Release by Cultured Rat Hepatocytes. European Journal of Biochemistry. 229(2). 349–355. 8 indexed citations
19.
Steckholzer, Ursula, et al.. (1995). 122 SEVERE TRAUMA LEADS TO ENDOTOXIN TOLERANCE WITH DECREASED RELEASE OF PROINFLAMMATORY CYTOKINES. Shock. 3(5). 38–38. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026